Ben A. Van Hout

Regent Court, 30 Regent Street
Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany.

Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany.

Journal: The Journal of dermatological treatment

Published: October 27, 2024

Using the Online Elicitation of Personal Utility Functions Approach to Derive a Patient-Based 5-Level Version of EQ-5D Value Set: A Study in 122 Patients With Rheumatic Diseases From Germany.

Using the Online Elicitation of Personal Utility Functions Approach to Derive a Patient-Based 5-Level Version of EQ-5D Value Set: A Study in 122 Patients With Rheumatic Diseases From Germany.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: May 25, 2023

Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences.

Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: November 13, 2022

Exploring health preference heterogeneity in the UK: Using the online elicitation of personal utility functions approach to construct EQ-5D-5L value functions on societal, group and individual level.

Exploring health preference heterogeneity in the UK: Using the online elicitation of personal utility functions approach to construct EQ-5D-5L value functions on societal, group and individual level.

Journal: Health economics

Published: August 25, 2022

Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.

Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.

Journal: Advances in therapy

Published: January 08, 2022

The Online Elicitation of Personal Utility Functions (OPUF) tool: a new method for valuing health states.

The Online Elicitation of Personal Utility Functions (OPUF) tool: a new method for valuing health states.

Journal: Wellcome open research

Published: December 22, 2021

An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.

An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.

Journal: Advances in therapy

Published: May 06, 2021

Critical appraisal and issues regarding generalisability of comparative effectiveness studies of NOACs in atrial fibrillation and their relation to clinical trial data: a systematic review.

Critical appraisal and issues regarding generalisability of comparative effectiveness studies of NOACs in atrial fibrillation and their relation to clinical trial data: a systematic review.

Journal: BMJ open

Published: February 02, 2021

Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation.

Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation.

Journal: Journal of clinical medicine

Published: November 07, 2020

Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis.

Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: July 17, 2020

Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden.

Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden.

Journal: European heart journal. Quality of care & clinical outcomes

Published: May 19, 2020

Mapping EQ-5D-3L to EQ-5D-5L.

Mapping EQ-5D-3L to EQ-5D-5L.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: May 19, 2020

Showing 1-12 of 46

Last Updated: 09/26/2026